0 -stearoyloxy)triacontanamido]octadec-4-ene-1,3-diol (2) and (2S,3R,4E,6R)-2-[(30 0 -stearoyloxy)triacontanamido]octadec-4-ene-1,3,6-triol (4), are minor components of the human stratum corneum. We synthesized these ceramides by employing olefin cross metathesis as the key reaction for constructing their !-hydroxytriacontanoyl part (13).
The stratum corneum is the upper layer of the epidermis. It protects the body from loss of water and against intrusion of environmental damaging factors. 2, 3) Ceramides are the major lipid components, accounting for 30-40% by weight of the mammalian stratum corneum.
2) To date, nine subclasses of free extractable ceramides have been identified from the human stratum corneum. [4] [5] [6] [7] [8] Among these, ceramides 1, 4, and 9 are structurally unique sphingolipids, and respectively comprise 8%, 5%, and 6% of free and extractable ceramides. 4) They have a long acyl chain possessing an !-hydroxy group esterified with a fatty acid like linoleic acid. It has been proposed that these esterified ceramides function as molecular rivets in locking together the multiple intercellular lamellae with their alkyl chains in the stratum corneum. 9, 10) Esterified ceramides 1, 3, and 5 ( Fig. 1) are the major respective components of ceramides 1, 4, and 9. [4] [5] [6] [7] [8] They have an !-linoleoyloxy acyl group, but it has not yet been clarified why the linoleoyl group is so abundantly distributed in the epidermal ceramides. We have reported the synthesis of 1 and 3, and confirmed their structures as shown. 11, 12) Due to the fragility of the 1,4-diene structure of the linoleoyl part, ceramides 1 and 3 are unstable. Therefore Dr. S. Hamanaka, a dermatologist, asked us to synthesize !-stearoylated ceramides 2 and 4 as stable standard samples for a dermatological study. It is known that 2 and 4 are natural minor components of ceramides 1 and 4. 4) We reported in 1992 a synthesis of !-stearoyloxy ceramide with an icosasphingosine (C 20 ) chain. 13) However, the synthesis of its sphingosine (C 18 )-type ceramide (2) and 6-hydroxysphingosine-type one (4) have not previously been reported.
We synthesized 2 and 4 from 15-pentadecanolide (6) in 9 steps as shown in Schemes 1 and 2. The respective overall yields of 2 and 4 were 17% and 12%, based on 6. We employed olefin cross metathesis with Grubbs's first-generation catalyst as the key reaction to construct their !-hydroxytriacontanoic acid part. [14] [15] [16] 
Results and Discussion
Our previous synthesis of 1 and 3, 11, 12) including icosasphingosine-type ceramide 1, 13) employed the Wittig reaction for constructing their !-hydroxytriacontanoyl part. 17) Although the overall yield is generally very high, the Wittig reaction requires the cumbersome preparation of both an ylide and an aldehyde, and makes the synthetic pathway redundant. We chose in this present synthesis the olefin cross metathesis reaction to assemble the long acyl chain part. [14] [15] [16] Figure 2 summarizes the retrosynthetic analysis of 2 and 4. We considered that the synthesis of the target ceramides, including 1 and 3, could be achieved by a two-step conversion, acylation and deprotection, from To construct C, we planned to employ the olefin cross metathesis reaction with Grubbs's first-generation catalyst between D and E which could be readily prepared from commercially available 15-pentadecanolide (6). Scheme 1 shows how !-acetoxytriacontanoic acid 13 (= C) was synthesized from 6. Lactone 6 was converted to alken-1-ol 7 (= D) via the corresponding hemiacetal by reduction with diisobutylaluminum hydride and subsequent treatment with the Wittig reagent in a onepot procedure (64%). Acetylation of 7 gave 8 (= E) in a 99% yield. The olefin cross metathesis reaction between 7 and 8 (a 1:1 mixture) in the presence of 5 mol % of Grubbs's first-generation catalyst gave desired olefin 9 (47%, E/Z = ca. 4:1, determined by a 500 MHz 1 H-NMR analysis) together with diacetate 10 (22%) and diol 11 (23%). [14] [15] [16] These compounds were separated by column chromatography, and the olefin cross metathesis reaction of a 1:1 mixture of separated 10 and 11 provided three kinds of olefin, 9 (45%), 10 (23%), and 11 (20%). The reaction mixture needed to be loaded into a chromatography column while it was hot after stirring under reflux for 3 h to achieve equilibrium of the metathesis reaction. Purification after cooling to room temperature resulted in respective isolated yields for 9, 10 and 11 of 39% (E/Z = ca. 4:1), 23% (E/Z = ca. 4:1) and 29% (E/Z = ca. 9:1). The solubility of 11 in dichloromethane was lower than that of 9 and 10, and it separated out from the solution when it was cooled to room temperature. Therefore, 11 was regenerated from 9 through the metathesis reaction in the solution. This decreased the yield of 9, and 11 was obtained in more than the theoretical yield in this case. Hydrogenation of 9 yielded 12 (93%) which was then oxidized with the Jones chromic acid reagent to give acid 13 in a 96% yield.
Many methods have been published to construct the sphingosine chain. 18, 19) We prepared it in the present synthesis from commercially available and inexpensive phytosphingosine 14 20) via Kim's azide 15 (Scheme 2). 21) Protection of the 3-hydroxy group of 15 as a tert-butyldimethylsilyl (TBS) ether provided 16. Reduction of 16 with trimethylphosphine and subsequent alkaline treatment gave amine 17a (= B) in an 88% yield. Condensation of 17a with acid 13 afforded 18a (98%), and deacetylation of 18a yielded the key intermediate, alcohol 19a (= A), in a 90% yield. Acylation of the !-hydroxyl group of 19a with stearoyl chloride gave 20a (91%) which was then desilylated with tetrabutylammonium fluoride (TBAF) to furnish one of the desired !-stearoyloxy ceramides, 2. The overall yield was 17% in 9 steps from 6.
Synthesis of a 6-hydroxysphingosine chain like 17b has been reported by three groups. 12, [22] [23] [24] Another target ceramide (4) was synthesized from amine 17b, which had been prepared according to the method in our previous report, 12) in the same manner as that just described. The overall yield of 4 was 12% based on 6 in 9 steps.
Synthesized 2 and 4 were hardly soluble in CHCl 3 , although it has been reported that 1 and 3 were soluble in CHCl 3 even at room temperature. 11, 12) The physical properties of these esterified ceramides might be influenced by the nature of their !-acyloxy groups. The respective melting points of the synthesized !-stearoyloxy ceramides (2 and 4) were 94-95 C and 109-111
C. The bioactivity of these ceramides is now under investigation, and will be reported in due course by Dr. S. Hamanaka.
Conclusion
The minor ceramide components (2 and 4) of the human stratum corneum were synthesized from sphingosine bases (17a and 17b) and !-acetoxytriacontanoic acid (13) . The latter was prepared by olefin cross metathesis between hexadec-15-en-1-ol (7) and its acetate (8) , employing Grubbs's first-generation catalyst. The preparation of 7 was accomplished by a onepot reduction/Wittig reaction procedure from 15-pentadecanolide (6).
Experimental
Refractive indices (n D ) were measured with an Atago 1T refractometer. Melting point (mp) data were recorded with Yanaco MP-S3 melting point measuring apparatus and are uncorrected. Optical rotation values were measured with a Jasco P-1010 polarimeter, and IR spectra were measured with a Jasco FT/IR-460 plus spectrometer.
1 H-NMR spectra (TMS at H ¼ 0:00 or pyridine at H ¼ 7:55 as the internal standards) and 13 C-NMR spectra (pyridine at 135.5 as the internal standard) were recorded with a Varian VNMRS-500 spectrometer. High-resolution mass spectrometry (HRMS) was performed with a Jeol JMS-700 [electron ionization (EI)] or Waters MALDI SYNAPTÔ G2 HDMS [electrospray ionization (ESI)] mass spectrometer. Column chromatography was performed with Merck Kieselgel 60 Art 1.07734.
Hexadec-15-en-1-ol (7). To a stirred suspension of methyltriphenylphosphonium bromide (4.47 g, 12.5 mmol) in dry THF (20 mL) was added a solution of lithium bis(trimethylsilyl)amide (LHMDS, 1.0 M in THF, 12.5 mL, 12.5 mmol) at 0 C. The mixture was stirred for 2 h at 0 C to prepare a solution of methylenetriphenylphosphorane.
To a stirred solution of 6 (1.44 g, 5.99 mmol) in dry toluene (30 mL) at À78
C, a solution of diisobutylaluminum hydride (DIBAL-H, 1.02 M in toluene, 6.5 mL, 6.6 mmol) was slowly added over 30 min. After stirring at À78 C for 30 min, a yellow solution of the phosphorous ylide just prepared was slowly added over 10 min. The mixture was gradually warmed to room temperature while stirring for 17 h. The reaction was then quenched with 1 M hydrochloric acid, and the mixture was stirred for 30 min. The mixture was extracted with EtOAc, and the combined organic phase was successively washed with water, a saturated aqueous NaHCO 3 solution and brine, dried with MgSO 4 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (50 g, hexane/EtOAc = 10:1) to give 7 (928 mg, 64%) as colorless needles. IR and 1 H-NMR spectra were in accordance with those reported in ref. Method B: A suspension of 10 (277 mg, 0.516 mmol), 11 (234 mg, 0.517 mmol), and Grubbs's first-generation catalyst (Aldrich, 22 mg, 0.027 mmol, 5.2 mol % to 10) in dry and degassed CH 2 Cl 2 (20 mL) was stirred under reflux for 3 h in an argon atmosphere. The mixture was then diluted with hot CHCl 3 and purified by column chromatography on silica gel (30 g, CHCl 3 /MeOH = 100:1, 100:2, and 100:3 for 10, 9, and 11, respectively) with the same procedure as that just described to give 10 (129 mg, 23%, E/Z = ca. 4:1), 9 (288 mg, 45%, E/Z=ca. 3:1) and 11 (95 mg, 20%, E/Z = ca. 5:1).
30-Hydroxytriacontyl acetate (12).
To a stirred solution of 9 (498 mg, 1.01 mmol) in THF (40 mL), 10% Pd-C (Kawaken, 84 mg) was added. After stirring at room temperature for 15 h in a hydrogen atmosphere, the mixture was filtered and then concentrated in vacuo. 30-Acetoxytriacontanoic acid (13) . To a stirred suspension of 12 (422 mg, 0.849 mmol) in dry acetone (30 mL), a solution of Jones CrO 3 (2.67 M, 953 mL, 2.54 mmol) was added in one portion at room temperature. After stirring at 60 C for 30 min, the mixture was diluted with water. The precipitate was collected by filtration and then washed with water. After air-drying, 415 mg (96%) of 13 was obtained as colorless powder and was used in the next step without further purification. The analytical sample was obtained by column chromatography on silica gel (CHCl 3 /MeOH = 50:2 (16) . To a stirred solution of 15 21) (574 mg, 1.02 mmol) and 2,6-lutidine (355 mL, 3.05 mmol) in dry CH 2 Cl 2 (10 mL), tert-butyldimethylsilyl trifluoromethanesulfonate (TBSOTf, 351 mL, 1.53 mmol) was added at 0 C. After stirring at 0 C for 15 min, the reaction was quenched with MeOH (0.5 mL), and the mixture was concentrated in vacuo. The residue was diluted with EtOAc, and successively washed with a saturated aqueous NaHCO 3 solution, water and brine, dried with MgSO 4 , and concentrated in vacuo. 
To a stirred solution of 16 (447 mg, 0.659 mmol) in dry THF (15 mL), a solution of trimethylphosphine (1.0 M in THF, 3.3 mL, 3.3 mmol) was added at room temperature. After stirring at room temperature for 17 h, an aqueous solution of NaOH (1.0 M, 6.6 mL, 6.6 mmol) was added to the mixture. The resulting mixture was stirred at room temperature for 2 h. The mixture was then poured into water and extracted with EtOAc. The separated organic phase was successively washed with water, a saturated aqueous NaHCO 3 solution and brine, dried with K 2 CO 3 , and concentrated in vacuo. The residue was purified by column chromatography on silica gel (30 g, hexane/EtOAc = 9:1) to give 17a 
